Skip to NavigationSkip to content

News

The FDA has approved Xadago (safinamide) as a supplementary treatment for Parkinson’s in patients currently taking levodopa/carbidopa and who are...
A Chicago man has become the first person ever documented to be cured of congenital dyserythropoietic anaemia (CDA), a rare and debilitating blood...
GSK has officially broken ground on the expansion of its site in County Durham. The expanded site will be an aseptic sterile facility that will make...
It looks like the once promising future for serelaxin may be in tatters, as it failed to impress in a Phase 3 trial to reduce cardiovascular...
Novartis released data on patient’s reaction to Cosentyx for the treatment of psoriasis, finding that as many as 21% of patients maintained clear...
GBI Research has indicated that the non-small cell lung cancer (NSCLC) market in the Asia-Pacific (APAC) region is set to grow by more than 100% to...
Eli Lilly has announced that its trial of abemaciclib, in combination with fulvestrant, had met its primary endpoint of progression-free survival (...
The Indian Government has announced its intention to transform the nation into a hub for global biotech activity via its Biotechnology Industry...
Biogaran, the French generic manufacturer that is a subsidiary of Servier, has acquired a foothold in Nigeria with a 95% equity buyout of Swipha, the...
Array BioPharma has announced that it has pulled its new drug application (NDA) for its drug, binimetinib, for the treatment of NRAS-mutant melanoma...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches